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Chronic neutral phosphate supplementation induces sustained, renal
metabolic alkalosis. The aim of the present study was to test whether
intravenous neutral phosphate supplementation, recently shown in our
laboratory to acutely stimulate proton secretion in the distal nephron,
was able to induce a sustained metabolic alkalosis. Neutral Na and K
phosphate supplementation for seven days, with equivalent reduction in
chloride supply and unchanged intake of sodium and potassium, in
ADX rats receiving fixed physiological doses of aldosterone and dexa-
niethasone (group 1, N 7), was responsible for a severe metabolic
alkalosis (MA; [HCO] II 1.3 m, and pH 0.11 0.06 unit).
Metabolic alkalosis was at least in part of renal origin, since net acid
excretion (NAE) transiently increased, principally due to an increment
in titratable acid excretion rate. Balances were equilibrated for sodium
and negative for chloride and potassium, which may have contributed
to the severity of the MA. Chronic i.v. neutral Na phosphate, without
change in potassium and chloride supply, in ADX rats receiving the
same doses of steroids (group 2, N = 5), was responsible for a less
severe MA ( [HCO1] 7.5 0.9 m, and pH 0.07 0.01 unit), also
of renal origin. In this group, balances were positive for chloride and
sodium and equilibrated for potassium. Finally, neutral Na and K
phosphate supplementation with reduction in chloride supply in intact
rats (group 3, N = 4) was also able to induce a MA ( [HCO] 5.5 1.8
m, and z pH 0.06 0.01 unit) of renal origin, with balances negative
for chloride and equilibrated for potassium and sodium. In all groups,
the generation and maintenance of MA probably resulted from stirnu-
lated proton secretion in the distal nephron, as suggested by the
observed increase of PCO2 over HCO3 concentration ratio in the urine
and a fall in urine pH despite augmented urinary buffer content
throughout the phosphate infusion period. Glomerular filtration rate did
not significantly vary in any group. In conclusion, chronic supplemen-
tation of neutral phosphate appears to stimulate per se proton secretion
in the distal nephron, independently of sodium, chloride, and potassium
balances, and adrenal steroid secretion. Thus neutral phosphate sup-
plementation should be added to the previously known factors able to
induce MA.
In acute studies, infusion of sodium with neutral phosphate or
sulfate to sodium-depleted humans or dogs caused a sharp
reduction in urinary pH and an increase in acid excretion [1, 2].
These effects were attributed to the delivery of sodium with a
nonreabsorbable anion to the distal nephron that had been
stimulated to conserve sodium; it was suggested that the
administered anion affects urine pH and acid excretion through
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its influence on the transepithelial electrical gradient established
by active sodium transport across the renal tubular cells [1, 2].
According to this hypothesis, the magnitude of the lumen-
negative transepithelial potential difference would be deter-
mined by the relative penetrating ability of the available anion.
However, chronic infusions of sodium with a nonreabsorbable
anion are not expected to result in a sustained increase in net
acid excretion [I]. Indeed, the administered sodium is progres-
sively retained by the kidney and the resultant expansion of
extracellular fluid volume would suppress the avidity of the
distal nephron for sodium [1]. Experimental observations have
confirmed this view; chronic infusions of sodium sulfate in dogs
fed a low sodium diet or in humans with normal sodium intake
did not result in a sustained increase in net acid excretion or
increase in plasma bicarbonate concentration [3, 4].
Moreover, among the poorly reabsorbable anion, a specific
role for phosphate may be suggested on the basis of other
experiments. In our laboratory, we recently showed in the rat
that tubular fluid phosphate concentration acutely stimulates
proton secretion in collecting tubule independently of its anion
and buffer characteristics [5]. This explains the stimulation of
proton secretion in the collecting duct observed during acute
PTJ-I infusion in TPTX rats [61. These findings were consistent
with previous studies in which an acute infusion of neutral
phosphate, but not sulfate, has been shown to enhance urinary
net acid excretion in dogs fed a normal sodium intake [7]. Thus
tubular fluid phosphate, by its specific stimulating effect on
collecting duct proton secretion, may appear as a potent deter-
minant of net acid excretion. These results prompted us to test
whether a chronic infusion of neutral phosphate may be respon-
sible for a sustained increase in net acid excretion and plasma
bicarbonate concentration, independently of factors already
known to induce metabolic alkalosis.
Methods
Sixteen male Sprague-Dawley rats, weighting 327 3 g, were
studied in unrestrained housed metabolic cages. After a seven-
day acclimatization period, catheters for chronic infusion and
blood samples were implanted under sterile conditions during a
light anesthesia (50 mg per 100 g body wt of i.p. pentobarbital).
A sterile polyethylene catheter (PE 10) and a sterile silicone
polymer catheter (Silastic no. 135, Dow Corning, UK) were
implanted into the aorta through the left femoral artery and into
the vena cava through the left femoral vein, respectively. Both
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catheters were exteriorized at the back of the neck through a
stainless steel ring sewed on the skin and then inserted into a 30
cm-long stainless steel protective spring. The inferior end of
this spring was bound up to the ring and the superior one was
bound up to a swivel canulla (Instech Laboratories, Horsham,
USA) which allowed animal to freely move in the cage without
any risk of twisting the catheters. The arterial catheter was
filled with a sterile polyvinylpyrolidone solution (Prolabo,
France) and its extremity was heat sealed. The venous catheter
was connected to the pump through the canulla and continuous
infusion of adequate solution was started. Some rats were
surgically adrenalectomized (ADX), through a bilateral poste-
rior incision, just after the implantation of catheters, and then
received continuous infusion of physiological replacement
doses of aldosterone (0.5 sg/l00 g body wt/day) and dexameth-
asone (1.2 sg/l00 g body wt/day) throughout the study [81,
whereas other rats were sham operated.
Blood samples were obtained from the arterial catheter,
previously emptied of polyvinylpyrolidone. Each blood sample
was immediately followed by a low rate transfusion (1 ml per 5
mm) of an adequate amount of whole blood obtained on the
morning of the study from another Sprague-Dawley rat that was
maintained on the same diet as the experimental rat, and either
ADX the day before or intact as appropriate. Urine was daily
collected throughout the study, in graduates containing water
saturated mineral oil and thymol crystals. At the end of each
seven-day period, glomerular filtration rate (GFR) was esti-
mated from inulin clearance (priming i.v. dose of 20 sCi of
[Methoxy-3H] inulin: New England Nuclear, Boston, Massa-
chusetts, USA; and sustained infusion of S sCi/hr). After a
90-minute equilibration period, a four hour urine collection was
begun and three blood samples were drawn during this period.
Protocols
Animals had free access to distilled water and were given
daily a fixed amount (20 g) of a regular rat chow that they
completely ate (A04, UAR, France). Mineral contents were in
g/kg of food: sodium, 2.4; chloride. 2.5; potassium, 6; calcium,
6; phosphorus, 5.9. The rate of continuous intravenous infusion
of adequate solutions was 1 mi/hr.
The study was divided into three successive, seven day
periods: control, neutral phosphate infusion and recovery. The
first period started 48 hours after surgery. Animals were divided
into 3 groups.
Group I (N = 7, 325 6 g).Intravenous chronic neutral
phosphate supplementation with equivalent reduction in chlo-
ride and unchanged infusion rates of sodium and potassium in
ADX rats receiving fixed doses of steroids. Infusate composi-
tions were (mM): NaCl, 115.4 and KCI, 167.5 during control and
recovery periods; NaH2PO4 10.63, Na2HPO4. 53.13, K,HPO4,
74.7 and KH2PO4, 17.9 during phosphate period.
Group 2 (N = 5, 324 4 g).lntravenous chronic neutral
phosphate supplementation without change in chloride supply
in ADX rats receiving the same daily fixed doses of steroids as
in Group 1. Infusion rates were unchanged for potassium but
increased for sodium. In addition, to avoid occurrence of
relative extracellular fluid (ECF) volume contraction during
recovery period, infused amount of sodium was held constant
over the last two periods. Infusate compositions were (mM):
NaC1, 115.4 and KCI, 167.5 during control period; NaCI, 115.4,
KCI, 167.5, Na2HPO4, 131.6 and NaH2HPO4, 26.3 during
phosphate period; and NaCI, 404.9 and KCI, 167.5 during
recovery.
Group 3 (N = 4, 336 5 g).Infusate compositions were the
same as in Group I for the three periods, but the rats were not
ADX (sham-operated) and therefore able to modulate the
endogenous secretion of steroids.
Analytical procedures and calculations
[Methoxy-3H1 inulin activity in plasma and urine was mea-
sured by scintillation counting (LKB, Bromma, Sweden). Urine
and plasma sodium and potassium concentrations were mea-
sured by indirect potentiometry (Model E2A, Beckman Instru-
ments, Fullerton. California, USA); urine and plasma chloride
concentrations by a chloride titrator (Model CMTIO, Radiom-
eter. Copenhagen, Denmark); urine and plasma phosphorus
concentrations by colorimetric determination. Plasma protein
concentration was determined by refractometry; pH and PCO2
in plasma and urine by a gas analyzor (Radiometer), total CO2
in urine by thermic conductivity (Model 965, Corning); titrat-
able acid and ammonium urinary concentrations were deter-
mined by titration methods [9, 10]. Titratable acid attributable
to phosphate was calculated using the Henderson-Hasselbaich
equation and a pK of 6.8. Apparent bicarbonate space (A.B.S.)
was estimated for each group of animals, using an algorithm
developed by Fernandez, Cohen and Feldman [11]:
2.6A.B.S. = 0.4 + x body weight[HCO1]p
in which [HCO3 - ]p is plasma bicarbonate concentration.
Statistical analysis has been performed by one-way and
two-way analysis of variance, Scheffé, nonparametric
Wilcoxon, and paired t-test as appropriate. Results are ex-
pressed as mean SEM. P < 0.05 was considered significant.
Results
Effects of chronic supplementation of neutral phosphate with
reduction in chloride supply and unchanged in take of sodium
and potassium, in ADX rats receiving fixed physiological
replacement doses ofsteroids (Group 1)
The design of this group was to investigate the effects of
chronic neutral phosphate infusion while other factors known to
influence distal proton secretion (that is, plasma mineralocor-
ticoid concentration, sodium and potassium supply) were con-
trolled.
Acid-base changes. Plasma bicarbonate concentration in-
creased by the second day of phosphate administration and
remained elevated throughout this period. The difference in
bicarbonate concentration reached 11 1.3 m. Then plasma
bicarbonate concentration promptly fell to normal during the
recovery period. Plasma pH also increased (0.11 unit 0.06)
during phosphate infusion while PaCO, did not vary signifi-
cantly (Fig. I).
The time course of urine acid-base parameters is summarized
in Figure 2. Compared to control period, urinary pH was
decreased throughout the phosphate infusion period (7.05
0.01 vs. 7.24 0.05, P < 0.05) and then returned to values not
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Fig. 1. Effects of chronic supplementation of neutral phosphate and
chloride restriction on arterial acid-base composition in ADX rats
receiving a fixed Na and K supply and physiological replacement doses
of steroids (group 1). Values were tested for significant differences from
control: * P < 0.01; Ap < 0.001.
different from control during recovery (7.36 0.03). Mean daily
urinary net acid excretion (NAE), expressed as the difference
from end-control period values, significantly increased on the
first day of phosphate infusion (increment of 0.55 0.14
mmolI24 hr, P < 0.05) and then progressively decreased to
values not different from controls during the last four days of
this period. During the recovery period NAE transiently de-
creased to values lower than controls as expected (Fig. 2). The
cumulative negative balance of proton calculated during phos-
phate infusion period (—1.87 1.61 mmol) was not significantly
different from the calculated cumulative retention of proton
during recovery (2.59 1.22 mmol). The corresponding addi-
tion of bicarbonate (1.87 mmol) to an estimated A.B.S. of 159
ml (according to the animals' mean weight and control plasma
bicarbonate concentration) was expected to induce an increase
in plasma bicarbonate concentration of 11.8 m, a value very
close to that actually observed (see above). Mean daily urinary
titratable acid excretion was increased throughout the phos-
phate infusion period (0.37 0.04 vs. 0.01 0.02 mmolJ24 hr,
P < 0.01) and then promptly returned to values similar to
controls during recovery (0.01 0.01 mmol/24 hr). Calculated
titratable acid excretion attributable to phosphate was 0.01
0.06, 0.27 0.15, and 0.00 0.07 mmol/24 hr during the
control, phosphate, and recovery periods, respectively, which
was thus consistent with measured titratable acid excretion.
Mean daily ammonium excretion remained unchanged through-
out the study (0.54 0.03, 0.54 0.06, and 0.55 0.09, in
control, experimental, and recovery periods, respectively).
Mean daily urinary bicarbonate excretion decreased on the first
day of phosphate infusion period (0.97 0.08 vs. 1.19 0.06
mmoll24 hr), although not significantly, and then increased to
values above controls during the last 6 days of the experimental
period (1.30 0.07 vs. 1.19 0.06 mmol/24 hr, P < 0.005).
During recovery period, mean daily bicarbonate excretion
increased further (1.56 0.07 mmol/24 hr, P < 0.03), which
accounted for the decrease in NAE.
The urinary PCO2 over bicarbonate concentration ratio, used
as an index of the collecting duct proton secretion rate [12], was
significantly higher throughout the phosphate infusion period
than the control value (4.10 0.28 vs. 2.06 0.36, P < 0,05).
In addition, a positive linear correlation between the latter
index and urinary phosphate concentration was found when the
data of the three periods were pooled (Fig. 3).
Miscellaneous. Plasma sodium and phosphate concentrations
remained unchanged, whereas potassium and chloride concen-
trations decreased significantly during phosphate infusion pe-
riod and returned to normal during recovery period (Table 1).
As expected, mean urinary phosphate excretion dramatically
increased during phosphate infusion (3.23 0.19 vs. 0.20
0.04 mmol/24 hr) as well as urinary phosphate concentration
(104.7 6.7 vs. 7.9 1.1 mM). Both values returned to control
levels during recovery.
Sodium, potassium, and chloride balances were estimated as
the differences between intakes (intravenous and dietary) and
urinary excretion rates (Table 2). During control period, sodium
and chloride balances were equilibrated. Sodium balance was
equilibrated over the three periods; indeed, plasma protein
concentration, hematocrit, and GFR did not change over the
entire study. A negative cumulative balance for chloride devel-
oped as expected during phosphate period (—2.77 0.69 mmol,
P < 0.01) and repaired during recovery (2.99 1.23 mmol, P <
0.01). With respect to potassium balance, the discrepancy
between intake and urinary excretion rate during control period
may be attributed to potassium retention for normal growth, as
previously observed by others [13, 14]. Thus possible changes
in the potassium balance between periods were calculated from
the differences in urinary excretions. A negative cumulative
balance for potassium (—3.5 0.7 mmol, P < 0.001) also
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composition in rats of group 1. NAE: mean
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developed during phosphate period and remained unchanged
during recovery.
Thus, under conditions of fixed plasma gluco- and mm-
eralocorticoid concentrations and sodium balance equilibrium,
a frank metabolic alkalosis of renal origin occurred during
neutral phosphate infusion. However, negative balances for
chloride and potassium may have contributed to the severity of
metabolic alkalosis.
Effects of chronic supplementation of neutral phosphate and
sodium, without change in potassium and chloride intake, in
ADX rats receiving fixed physiological replacement doses of
steroids (Group 2)
This group was designed to investigate the effects of chronic
neutral phosphate infusion in the absence of negative chloride
and potassium balance.
Plasma and urine acid-base composition is shown in Figure 4.
Metabolic alkalosis also occurred during phosphate administra-
tion, but the elevations in plasma bicarbonate concentration (i
[HCO3I 7.5 0.9 mri, P < 0.01) and arterial pH ( pH 0.07
0.01 unit, P < 0.001) at the seventh day of phosphate infusion
were less important than in group I; both values returned to
near normal during recovery. Variations in urinary pH and
NAE during phosphate infusion were in the same direction as in
group 1, but less important. The cumulative negative proton
balance (—1.46 0.57 mmol, P < 0.05) during phosphate
infusion was followed by a statistically similar cumulative
retention of proton during recovery (2.44 0.69 mmol). Into an
estimated A.B.S. of 159 ml, such an addition of bicarbonate
(1.46 mmol) was expected to induce an increase in plasma
bicarbonate concentration of 9.2 m, which was consistent
with the observed value. As in group 1, mean daily titratable
acid excretion increased throughout phosphate infusion period
(0.41 0.01 vs. 0.03 0.01 mmol/24 hr, P < 0.001) while
ammonium excretion remained constant (0.60 0.03 vs. 0.61
0.03 mmol/24 hr). Titratable acid excretion attributable to
phosphate was 0.00 0.05 and 0.27 0.14 mmol/24 hr during
the control and phosphate periods, respectively. Mean bicar-
bonate excretion slightly increased (1.67 0.08 vs. 1.48 0.14
mmol/24 hr) mainly by the fourth day of the phosphate infusion
period, and thereby allowed NAE to return to near control
values. As in group I, urinary PCO2 rose during phosphate
infusion (124 6 vs. 77 9 mm Hg, P < 0.001) and corrected
during the third period (63 9 mm Hg).
Sodium, chloride and potassium cumulative balances are
depicted in Figure 4. A positive cumulative sodium balance
developed during phosphate administration (4.9 4.9 mmol)
and sustained after discontinuation of phosphate infusion.
Plasma sodium concentration did not change, Plasma chloride
concentration decreased during phosphate infusion (98.0 0.9
vs. 104.0 1.5 mii, P < 0.01). Urinary chloride excretion
remained unchanged (8.72 0.35 vs. 8.59 0.34 mmol/24 hr)
so that chloride balance was equilibrated; a positive cumulative
chloride balance (7.00 1.02 mmol; Fig. 4) developed during
recovery, according to the enhanced chloride supply. Thus, as
expected, chloride depletion did not occur in this group. Plasma
potassium concentration decreased during phosphate infusion
(3.34 0.26 vs. 4.30 0.24 ms, P <0.001), and remained so
during recovery (3.55 0.11 mM). Daily urinary potassium
excretion did not change during phosphate infusion (6.87 0.18
vs. 6.75 0,21 mmol/24 hr) and during the third period (6.63
0.15 mmol/24 hr). Therefore, the potassium balance remained
equilibrated throughout the study. GFR values tended to in-
crease during phosphate infusion (2.59 0.18 vs. 2.27 0.13
ml/min) and recovery (2.77 0.11 mI/mm), although not
significantly.
In conclusion, under conditions of fixed plasma gluco- and
mineralocorticoid concentrations, potassium and chloride bal-
ance equilibrium, and positive sodium balance, a metabolic
alkalosis of renal origin occurred during neutral phosphate
infusion.
Effect of chronic supplementation of neutral phosphate with
reduction in chloride intake, and unchanged intake of sodium
and potassium, in intact rats (Group 3)
This group was designed to determine the effects of pro-
longed neutral phosphate administration in animals with con-
trolled sodium and potassium intake but preserved ability to
regulate endogenous adrenal steroids secretion.
The main results are shown in Figure 5. The elevations in
plasma bicarbonate (X [HCO] 5.5 1.8 mrvi, P < 0.05) and pH
(X pH 0.06 0.01 unit, P < 0.05) at the seventh day of
phosphate infusion period were slightly less than those found in
group 2. Then these values returned to control during recovery.
Compared to the control period, urinary pH was decreased all
over the phosphate infusion (7.16 0.03 vs. 7.40 0.10, P <
0.01) and returned close to control values during recovery (7.39
0.06). The negative cumulative proton balance (—1.19 0,94
mmol) during phosphate infusion was followed by a similar
retention of proton during recovery (2.2 0.95 mmol). For an
assumed A.B.S. of 169 ml, according to the animals' mean
weight and control plasma bicarbonate concentration, such an
amount of added bicarbonate (1.19 mmol) would induce an
increase in plasma bicarbonate concentration of 7.04 m con-
sistent with the observed value.
The increase in titratable acid excretion (0.22 0.03 vs. 0.00
0.01 mmol/24 hr, P < 0.001) over the whole period mainly
accounted for changes in NAE excretion while ammonium
excretion remained constant (0.42 0.02 vs. 0.43 0.06
E
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Table 1. Effect of chronic infusion of neutraI phosphate on blood variables and glomerular filtration rate in rats of group I (N = 7)
Na K Cl Pi .Protein
gluier
Hct
%
GFR
mi/mmPeriod msi
Control
Day 7
Phosphate
Day 7
Recovery
Day 7
145.0
143.4
143.4
1.4
1.1
1.1
4.40 0.02
3.38 0.ISa
4.31 0.19
104.6
92.7
105.6
1.2
10,
2.0
2.18
2.24
2.01
0.09
0.10
0.16
49.3 1.9
53.7 2.7
53.0 1.9
44.6 1.0
44.0 0.8
44.6 2.5
2.87 0.04
2.90 0.01
2.57
Abbreviations are: Hct, hematocrit; GFR, glomerular filtration rate. Values are means SEM. Mean values were tested for significant differences
from control: a (P < 0.01), b (P < 0.001)
Table 2. Mean daily intakes (dietary and intravenous), urinary excretion rates for Na, K, Cl, and urinary Cl concentration in rats of group I(N 7)
Periods Daily balance
Na K Cl Cl
mMmmol/24 hr
Control Intake
Urinary excretion
4.38
4.14 0.21
7.02
6.49 0.2
8.19
8.13 0.28 305 25
Phosphate Intake
Urinary excretion
4.38
4.18 0.11
7.02
6.99 0.17
1.40
2.38 0.33 81 7
Recovery Intake
Urinary excretion
4.38
4.12 0.11
7.02
6.58 0.13
8.19
7.60 0.45 246 30
mmol/24 hr). Titratable acid excretion attributable to phosphate
was 0.00 0.06 and 0.16 0.12 mmol/24 hr during the control
and phosphate periods, respectively. Bicarbonate excretion
increased during phosphate period, mainly by the fifth day (1.39
0.17 vs. 1.17 0.21 mmoll24 hr), allowing NAE excretion to
return toward control values. Urinary PCO2 rose during phos-
phate infusion (115 5 vs. 78 16 mm Hg, P < 0.05), and
corrected during the third period (81 10 mm Hg). Because of
a slight decrease in urinary sodium excretion during phosphate
infusion (3.56 0.13 vs. 3.77 0.25 mmol/24 hr), cumulative
sodium balance tended to be positive, although not signifi-
cantly. A negative cumulative chloride balance (—3.54 1.40
mmol) developed during phosphate infusion which corrected
when chloride was reintroduced. Plasma potassium concentra-
tion remained unchanged during phosphate infusion (4.4 0.2
vs. 4.7 0.2 mM) and urinary potassium excretion tended to
decrease with a slight positive balance (0.69 1.25 mmol).
Finally, GFR values remained constant during phosphate infu-
sion (2.75 0.23 vs. 2.62 0.33 mllmin), as did plasma protein
concentration and hematocrit.
Discussion
This study demonstrates that a sustained metabolic alkalosis
of renal origin develops during chronic neutral phosphate
supplementation: (1) in ADX rats with fixed physiological
steroid replacement, equilibrated sodium balance and potas-
sium and chloride depletion (group 1); (2) in ADX rats with
fixed physiological steroid replacement, equilibrated chloride
and potassium balance and ECF volume expansion (group 2);
and (3) in intact rats with equilibrated sodium and potassium
balance but chloride depletion (group 3). Taken together these
findings demonstrate that phosphate administration was the
main factor that caused metabolic alkalosis in this study.
Metabolic alkalosis was generated by renal mechanisms since
net acid excretion increased while alkalosis was developing. In
each group of this study, the severity of metabolic alkalosis was
fully explained by the positive bicarbonate balance generated
by the kidney. Provided that the calculation of the A.B.S. is
valid for chronic metabolic alkalosis, no net hydrogen ion shift
between extra- and intracellular spaces occurred in our study.
The increase in NAE was mainly the consequence of enhanced
phosphaturia and lowered urinary pH since the enhancement in
titratable acidity attributable to phosphate accounted for 70 to
73% of the total increase in titratable acid excretion. The
stimulation of tubular proton secretion probably took place in
the distal nephron, as indicated by the increase in PCO2 over
bicarbonate concentration ratio in the urine, which occurred as
early as the first day of phosphate infusion. The stimulation of
collecting duct proton secretion was also attested by the de-
crease in the urinary pH despite an increase in the urinary
buffer content during phosphate infusion. This is in agreement
with the stimulatory effect of phosphate on distal proton secre-
tion reported in acute studies [5].
The results of this study indicate that renal mechanisms also
accounted for the maintenance of metabolic alkalosis induced
by phosphate infusion. Indeed, after metabolic alkalosis had
fully developed and a new steady state was reached, net acid
excretion returned to a stable rate not different from the rate
observed prior to phosphate infusion.
Two main mechanisms have been implicated in the mainte-
nance of metabolic alkalosis by the kidneys: first, a decrease in
GFR which prevents an increase in the filtered load of bicar-
bonate [151; second, an increase in bicarbonate tubular reab-
sorption [16]. In the present study, the main role seems to be
devoted to increased tubular reabsorption since GFR remained
stable in groups 1 and 3 and even tended to increase in group 2
during neutral phosphate infusion, so that the bicarbonate
filtered load increased during phosphate infusion in the three
groups. Indeed, the fractional excretion of bicarbonate (calcu-
lated on the last day of control and phosphate periods) remained
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constant in each group, indicating that an increase in absolute
tubular reabsorption of bicarbonate occurred during phosphate
infusion. The distal nephron probably contributed at least in
part to the increased tubular reabsorption of bicarbonate.
Indeed, the abnormally high PCO2 over bicarbonate concentra-
tion ratio in urine throughout the phosphate infusion period 12]
and the persistent decrease in urinary pH concomitant with an
increase in urinary phosphate concentration indicate a sus-
tained increase in distal proton secretion. This situation differs
strikingly from the renal response to chronic dietary bicarbon-
ate challenge in normal rat. In the latter situation, the distal
tubular reabsorption of bicarbonate is adequately lowered,
which prevents the occurrence of metabolic alkalosis [171.
Taken together, these results strongly support that the distal
nephron had a major role in both the generation and mainte-
nance of metabolic alkalosis. The lack of decrease of ammo-
nium excretion during metabolic alkalosis is surprising, since
metabolic alkalosis is known to depress ammonia synthesis in
proximal tubule [18]. Two mechanisms may have counterbal-
anced the latter effect: first, in all groups of rats, the observed
lowering in urinary pH, which decreases the urinary NH3
concentration by shifting the buffer equilibrium away from NH3
thereby enhancing the peritubular-to-lumen NH3 gradient [19],
has been shown to enhance ammonium excretion [20], Second,
hypokalemia observed in groups 1 and 2, has been reported to
stimulate ammonia synthesis [211.
The occurrence of metabolic alkalosis of renal origin during
phosphate administration in the present study leads us to
examine the different physiological mechanisms known to in-
duce this acid-base disturbance, such as mineralocorticoid
excess, ECF volume contraction, and chloride and potassium
depletion.
Mineralocorticoids are known to directly stimulate proton
secretion in the collecting duct, independently of their action on
ECF volume and plasma potassium concentration [22]. This
factor cannot be invoked per se in the present study since
animals of groups 1 and 2 had physiological steroid replace-
ment. However, it could be argued that a rather high sodium
supply together with a fixed aldosterone replacement might
have resulted in a state of relative mineralocorticoid excess and
attendant permanent stimulation of distal proton secretion; in
this case, phosphate administration, resulting in abundant distal
.
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indicates increased excretion), and cumulative
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a fixed Cl and K supply and physiological
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buffer delivery, would increase titratable acid and thus net acid
excretion without any further decrease in urinary pH. Indeed,
the urinary pH should have, if anything, increased during
phosphate infusion because the high urinary buffer content
should have limited urinary acidification by collecting duct
proton secretion. By contrast, in the present study urinary pH
steadily decreased in groups 1 and 2 during phosphate admin-
istration, suggesting that phosphate per se stimulated distal
proton secretion. Nevertheless it cannot be excluded that a
relative mineralocorticoid excess could have contributed to the
severity of the metabolic alkalosis observed in groups I and 2.
In addition, such a relative aldosterone excess cannot be
invoked in group 3 in which animals had an intact ability to
regulate endogenous aldosterone secretion that should have
been depressed by the high sodium supply.
ECF volume contraction has been shown to generate [23, 24]
and maintain [16] metabolic alkalosis by stimulating tubular
reabsorption of bicarbonate. In the present study, this factor
cannot be invoked since sodium balance was either equilibrated
(groups I and 3) or positive (group 2).
Chloride depletion has also been proposed to be a major
determinant in the maintenance of metabolic alkalosis [25, 26].
In groups I and 3, we cannot exclude that the observed chloride
depletion contributed to the maintenance of metabolic alkalo-
sis. However, a negative chloride balance is not a prerequisite
since in group 2, in which metabolic alkalosis also developed, a
positive chloride balance occurred (Fig. 4). In addition, urinary
chloride concentration was sufficiently high during phosphate
infusion in the three groups (80 mM) to suggest that phos-
phate-induced metabolic alkalosis was chloride-resistant.
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Fig. 5. Effects of chronic neutral phosphate
supplementation and chloride restriction on
arterial acid-base composition, urinary pH(s), cumulative variations in NAE (0; a
positive value indicates increased excretion),
and cumulative balances for Na, K, Cl, in
intact rats receiving a fixed Na and K supply
(group 3).
1190 Houillier ci at: Neutral phosphate-induced metabolic alkalosis
Selective dietary potassium depletion has been shown in rats
to generate metabolic alkalosis without variation in proton
balance [27—29]. Then the alkalosis is maintained by a decrease
in GFR and/or an increase in tubular reabsorption of bicarbon-
ate. It is possible that the potassium depletion in group 1
contributed to the severity of the metabolic alkalosis. However,
a negative potassium balance is not necessary for metabolic
alkalosis to occur during phosphate infusion, since in groups 2
and 3 the potassium balance remained equilibrated (Fig. 5).
Since metabolic alkalosis has developed independently of
variations in Na intake and ECF volume, chloride and potas-
sium balance, and adrenal steroid secretion, chronic neutral
phosphate infusion appears to stimulate per se distal tubular
proton secretion sufficiently to generate and sustain a metabolic
alkalosis.
The present results extend to chronic situations those previ-
ously obtained from acute studies in our laboratory. We have
recently stressed in acute studies that phosphate is a potent
stimulus for acidification in the collecting duct, and that the
degree of stimulation is positively correlated to the urinary
phosphate concentration [5]. The mechanism remains uncer-
tain; some degree of inhibition of the luminal Cl/HCO
exchange responsible for bicarbonate secretion by the /3 inter-
calated cells might be considered since, in groups 1 and 3, the
complete replacement of chloride by neutral phosphate in
perfusate (but not in the chow) lowered the urinary chloride
concentration in the final urine from # 300 to # 80 mM.
However metabolic alkalosis occurred in group 2, in which a
high urinary chloride concentration (>100 mM) was maintained
during phosphate infusion. Therefore, a direct stimulation by
phosphate of proton secretion by alpha intercalated cells seems
much more likely. As discussed in the introduction, the poor
reabsorbability of the anion phosphate is not sufficient to
account for a sustained increase in tubular proton secretion and
thus metabolic alkalosis. Indeed, chronic administration of
another poorly reabsorbable anion, sulfate, is not accompanied
by metabolic alkalosis [3, 41. Urinary phosphate has also been
suggested to act via its buffer characteristics [71, but the latter
properties cannot account for the observed fall in urinary pH.
The capacity of phosphate to strongly stimulate distal proton
secretion may be due to additional mechanisms, as discussed in
a previous paper from our laboratory [5]. Thus, it can be
proposed that, by combining these properties, high urinary
phosphate concentration accounted for a sustained increase in
distal tubular proton secretion that generated and maintained
metabolic alkalosis for up to seven days. This potent effect of
urinary phosphate could explain at least in part the generation
of metabolic alkalosis observed in experimentally-induced hy-
pei-parathyroid states in humans and animals, in which PTH-
induced phosphaturia persist for several days [reviewed in 5].
More generally, the role of neutral phosphate supply in the
pathogenesis of experimental metabolic alkalosis ought to be
reappraised, particularly in some situations in which chloride
depletion has been suggested to play a predominant role. For
example, in the model of chloride-depletion alkalosis generated
in the rat by peritoneal dialysis with sodium and potassium
bicarbonate solutions [25], the chloride-free diet necessary to
maintain chloride depletion alkalosis without bicarbonate ad-
ministration contained neutral sodium phosphate, as pointed
out previously [30]. In other experiments, recovery from met-
abolic alkalosis induced by gastric drainage in animals main-
tained on a low-sodium and low-chloride diet was prevented by
a sodium neutral phosphate supply whereas animals receiving
sodium chloride corrected alkalosis within 48 hours [311. In
metabolic alkalosis produced in humans by administration of
furosemide and maintained by restriction of sodium chloride
intake, an amount of sodium phosphate intake sufficient to
correct the negative sodium balance worsened the metabolic
alkalosis by increasing renal bicarbonate generation [26]. Taken
together, these observations raise the possibility of a role for
neutral phosphate administration, besides chloride depletion, in
the pathogenesis of metabolic alkalosis. Thus, neutral phos-
phate supplementation should be added to the previously
known factors able to induce metabolic alkalosis.
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